Add BrightSurf on Google Email

Some tumors wire themselves into the nervous system; a new review asks whether psychedelics can answer back

A new review examines the relationship between tumors and the nervous system, suggesting that psychedelics may be able to 'listen' to the system and provide relief from cancer-related symptoms. The review also explores the potential for psychedelics to modulate the immune system and reduce inflammation in cancer patients.

SourceGenomic Press·JournalPsychedelics·TypeLiterature review·DateNov 10, 2026

Cambridge scientists use AI to develop bird flu vaccine that outperforms current stockpiled jab

A University of Cambridge team has developed an AI-guided bird flu vaccine that provides complete protection against globally circulating variants in animal trials, outperforming current stockpiled vaccines that offer only 50% protection. The new vaccine uses a 'plug and play' approach to create safe, highly effective vaccines for a pl...

SourceUniversity of Cambridge·JournalCell Reports Medicine·DateNov 5, 2026

Study advances mechanistic insight into tuberculosis vaccine’s link to reduced dementia risk

Researchers found that mice genetically engineered to have dementia symptoms who received BCG vaccine showed reduced neurofibrillary tangles, sustained immune cell activation, and memory loss compared to untreated mice. BCG vaccination was also linked to reduced inflammation and improved cognitive function in the mice.

SourceJohns Hopkins Medicine·JournalScience Advances·TypeExperimental study·DateOct 21, 2026

Immune system is already active before birth

Researchers have found that neutrophils, white blood cells, are present in many tissues during embryonic development, performing functions similar to adult neutrophils. This discovery suggests that embryonic neutrophils may have roles in tissue development and homeostasis in addition to immune defense.

SourceUniversity of Turku·JournalNature Communications·DateOct 19, 2026

ILC2 cells emerge as key cellular interfaces bridging nervous and immune systems

Group 2 innate lymphoid cells (ILC2s) form tight anatomical associations with sensory, autonomic, and enteric nerve fibers, receiving neural regulation through activating and inhibitory pathways. ILC2s also secrete cytokines that can act back on neurons, forming positive feedback loops that modulate allergic and anti-infective immunity.

SourceImmunity & Inflammation·JournalImmunity & Inflammation·TypeSystematic review·DateSep 25, 2026

Researchers uncover dual role of B7-H3 in tumor immune suppression

Researchers identified a previously unknown pathway that prostate tumors leverage to suppress the immune system, reshaping the tumor microenvironment to resist treatment. Combining B7-H3-targeted therapy with MEK inhibition improved antitumor responses and prolonged survival in preclinical models of castration-resistant prostate cancer.

Researchers identify ANKRD11 as a brake on T-cell responses to chronic hepatitis B virus and cancer

Researchers identified ANKRD11 as a key regulator that suppresses CD8+ T cell activity during chronic hepatitis B virus infection and cancer. ANKRD11 deficiency reprograms CD8+ T cell differentiation to enhance immunity in chronic infection and cancer, making it a potential therapeutic target.

SourceChinese Academy of Sciences Headquarters·JournalNature Immunology·TypeExperimental study·DateSep 13, 2026

Pusan National University researchers uncover how chronic environmental stress drives immune dysfunction in cold tumors

Researchers at Pusan National University investigated how chronic environmental stress drives immune dysfunction in cold tumors, revealing a key driver of NK-cell maladaptation: the GDF15-AhR axis. This axis sustains activation of stress-sensing receptors, gradually exhausting NK cells and enabling immune escape.

SourcePusan National University·JournalSignal Transduction and Targeted Therapy·TypeExperimental study·DateAug 18, 2026

UCLA researchers receive NIH grant to boost the effectiveness of cancer immunotherapy

Researchers at UCLA Health Jonsson Comprehensive Cancer Center are developing drug-based strategies to enhance cancer immunotherapy for melanoma and potentially other cancers. They identified two promising compounds that could strengthen T cell interaction with cancer cells or make tumor cells more susceptible to destruction by T cells.

Kidney transplant despite poor initial conditions: New drug sustainably reduces immune response against donor organ

Researchers developed a new treatment strategy using the cancer medicine Teclistamab to reduce antibodies against potential transplants, improving transplant prospects for patients with unfavorable immunological profiles. The study successfully performed a kidney transplant in a patient who had been on the waiting list for over a decade.

SourceMedical University of Vienna·JournalNew England Journal of Medicine·DateJul 30, 2026

Building your immunity: Tissue-resident immune cells defend human lungs from viral, bacterial, and fungal infections

A recent study found that human lung tissue contains a vast reservoir of tissue-resident memory T cells (T RM cells) capable of targeting a range of viruses, bacteria, and fungi. These cells reside only in the lungs and can live for years, providing a vital line of defense against severe respiratory infections.

SourceLa Jolla Institute for Immunology·TypeExperimental study·DateJul 28, 2026

Immune cells use previously unknown pathway to eliminate AML

Scientists at MD Anderson Cancer Center have identified a previously unknown mechanism by which T cells attack and eliminate acute myeloid leukemia (AML) cells. The discovery reveals that AML cells use a CD64-dependent pathway to evade traditional MHC recognition, potentially explaining why AML is sensitive to immune-based treatments.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalProceedings of the National Academy of Sciences·DateJul 15, 2026

Scientists develop new, improved method to find and isolate the strongest cancer-fighting immune cells

A new method called ATTACH identifies strong interactions between T cells and cancer-specific proteins to isolate effective tumor-reactive T cells. This approach overcomes key challenges in immunotherapy development, offering a rapid and accessible way for isolating rare immune cells.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalJournal for ImmunoTherapy of Cancer·DateJul 8, 2026

CDI Lab publishes two companion papers explaining immune ‘exhaustion’ - and how we might prevent it

Scientists at Hackensack Meridian Health's CDI Lab published two companion papers explaining the 'exhaustion' of key immune cells. The first paper identified Id proteins as determinants of exhausted CD8+ T cell fate, while the second paper revealed CTCF's role in dynamic enhancer activation and invariant barriers.

SourceHackensack Meridian Health·JournalNature Immunology·TypeExperimental study·DateJul 8, 2026

Are lung cancer tumors hijacking the nervous system?

A new study by Thales Papagiannakopoulos and colleagues found that lung cancer tumors talk directly to the nervous system through sensory neurons in the lungs, promoting cachexia. Silencing these nerves or blocking the production of prostaglandin E2 (PGE2) reduced cachexia, suggesting a potential therapeutic strategy.

SourceSalk Institute·JournalScience·DateJul 2, 2026

Physical exercise could help modulate the immune response in type 1 diabetes

A review published in Diabetes Care suggests that physical exercise could play a role in promoting immune regulation, preserving beta-cell function, and reducing inflammation in type 1 diabetes. The evidence highlights the potential benefits of exercise on immune profiles displaying anti-inflammatory characteristics.

SourceGermans Trias i Pujol Research Institute·JournalDiabetes Care·TypeLiterature review·DateJun 23, 2026

Antibody clues could improve long COVID care and prognosis

A study by Okayama University researchers revealed that SARS-CoV-2 antibody levels can assess infection history, symptom severity, and cognitive complications in long COVID. The findings suggest that declining S-antibody levels may indicate a greater risk of neurological complications.

SourceOkayama University·JournalBritish Journal of Biomedical Science·TypeObservational study·DateJun 12, 2026

Body clock found to control inflammatory responses in macrophages

Researchers from Kyushu University discovered that the circadian clock protein BMAL1 drives macrophages towards a pro-inflammatory M1 state by activating inflammatory signaling pathways. This mechanism links the body clock to intracellular metabolism and immune function, offering new insights into treating inflammatory diseases.

SourceKyushu University·JournalCell Reports·TypeExperimental study·DateJun 11, 2026